Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Oral Activated Charcoal on Parasite Clearance Rates in Response to Intravenous Artesunate in Malian Children With Uncomplicated Plasmodium Falciparum Malaria

Next Previous
Trial Profile

Effect of Oral Activated Charcoal on Parasite Clearance Rates in Response to Intravenous Artesunate in Malian Children With Uncomplicated Plasmodium Falciparum Malaria

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Artesunate (Primary) ; Amodiaquine; Charcoal
  • Indications Malaria
  • Focus Adverse reactions; Biomarker; Therapeutic Use

Most Recent Events

  • 30 Jul 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
  • 07 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2015 to 1 Mar 2016.
  • 07 Apr 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top